The state of Connecticut in April awarded close to $4 million to Yale scientists to study ways in which human embryonic stem cells can be used to treat such ailments as spinal cord injuries, cancer, and mental retardation. The grants were made by the Connecticut Stem Cell Research Advisory Committee, formed in 2005 when the state allocated $100 million over 10 years to promote such research. Connecticut was the third state to pass legislation allocating funds for the study of embryonic stem cells.
Five Yale researchers received grants worth a total of $2.5 million, and seven others received seed grants worth a total of $1.4 million. This latest round of funding will support such research projects as remyelination of nonhuman-primate spinal cords and the use of transposons—sequences of DNA that can change position within the genome of a single cell—for genetic manipulation of human embryonic stem cells.
Previous Article
Emergency medicine a department
Next Article
Downs fellows around the globe